By Katharine Jackson WASHINGTON (Reuters) – Democratic U.S. Senator John Fetterman returned to work on Monday after weeks of treatment for depression, bringing a crucial vote back to a Senate narrowly controlled by Democrats. The Pennsylvania senator, 53, waved to cameras as he entered the Capitol in his customary hoodie and shorts. “It’s great to…
By Brendan Pierson (Reuters) -E-cigarette company Juul Labs Inc and its former largest investor, Marlboro maker Altria Group Inc, on Monday settled claims by the state of Minnesota that accused them of fueling teen vaping addiction. The settlement was announced by Minnesota Attorney General Keith Ellison and by Juul as a trial in the case,…
By Horacio Soria and Juan Carlos Bustamante BUENOS AIRES (Reuters) – Argentine, fighting one of its worst outbreaks of dengue in recent years, is sterilizing mosquitoes using radiation that alters their DNA before releasing them into the wild. The South American country has this year recorded over 41,000 cases of the disease transmitted by mosquitoes,…
(Reuters) – Eli Lilly and Co said on Monday it will invest an additional $1.6 billion at its two new manufacturing sites in Indiana, United States to support the manufacturing of its recently approved cancer drug, Jaypirca, among others. The company’s total investment commitment in the facilities now stands at $3.7 billion, Eli Lilly said….
By Blake Brittain WASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear Novartis Pharmaceuticals Corp’s bid to revive a key patent on its blockbuster multiple sclerosis drug Gilenya that was invalidated amid a legal dispute with China’s HEC Pharm Co Ltd. The justices turned away an appeal by Novartis of a lower court’s…
HONG KONG/LONDON (Reuters) – HSBC’s biggest shareholder Ping An is likely to vote in favour of splitting the bank up at its annual investor meeting on May 5, a source familiar with the Chinese insurer’s thinking said on Monday. The source said Ping An would vote in favour of two resolutions tabled by individual investor…
(Reuters) – Merck & Co expects a research-and-development charge of about $10.3 billion, or $4 per share, this year as the drugmaker accounts its deal for Prometheus Biosciences Inc as an asset acquisition, CFO Caroline Litchfield said. The deal is expected to hit Merck’s profit by 25 cents per share in the first 12 months,…
By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing the market with its EpiPen auto-injector, a device used to treat severe allergic reactions. The justices turned away Sanofi’s appeal of a…
By Julie Steenhuysen and Michael Erman (Reuters) – An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck’s immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday. The findings suggest that…
BEIJING (Reuters) – Beijing’s subway has dropped mandatory mask requirements for travellers, local media reported on Sunday, days after a Chinese health expert said the threat of COVID-19 to humans is no longer at a serious level. The mask move is in line with broader measures by China, which said last week it was now…
